Double-filtration plasmapheresis (DFPP), an advanced blood-cleaning procedure, is equally effective as high-dose corticosteroids for treating acute attacks associated with…
Articles by Steve Bryson, PhD
A blood test measuring levels of the GPR37 protein may help diagnose neuromyelitis optica spectrum disorder (NMOSD), assess disease…
The gut hormone GLP-1 may contribute to brain inflammation in people with neuromyelitis optica spectrum disorder (NMOSD), leading to…
Nearly all adults with neuromyelitis optica spectrum disorder (NMOSD) experience headaches, especially migraines, a single-center study in Iran suggests.
Ultomiris (ravulizumab), an approved infusion therapy for adults with neuromyelitis optica spectrum disorder (NMOSD), is closer to being…
Using noninvasive eye scans may help clinicians to determine if patients — particularly those in early disease stages — have…
Infection rates were consistently lower in adults with neuromyelitis optica spectrum disorder (NMSOD) treated with Enspryng (satralizumab-mwge) over…
Starting off-label treatment with tocilizumab after the first disease attack in neuromyelitis optica spectrum disorder (NMOSD) is more effective…
Self-reactive antibodies linked to other autoimmune diseases are more common in people with neuromyelitis optica spectrum disorder (NMOSD) than…
Enspryng (satralizumab-mwge) promotes an anti-inflammatory profile in plasmablasts, the immune cells that produce large amounts of the self-reactive antibodies…